Ketamine Infusions for Anxiety and PTSD: What Patients Should Know
Why Anxiety Disorders Are So Difficult to Treat
Anxiety disorders, including generalized anxiety disorder, social anxiety, and PTSD, are among the most common mental health conditions in the world. Yet they remain some of the hardest to treat effectively. Standard first-line treatments like SSRIs, SNRIs, and therapy work well for many people, but a significant portion of patients find that their symptoms persist even after trying several different medications or spending years in therapy.
There are a few reasons for this. Traditional medications often work by adjusting serotonin or norepinephrine levels – neurotransmitters closely linked to mood regulation. But for some people, anxiety and PTSD are rooted deeper in the brain’s stress-response systems and neural pathways. When those underlying circuits don’t respond to standard treatments, the relief stays partial or short-lived.
This is precisely where ketamine enters the picture.
A New Path in Anxiety Treatment
Ketamine isn’t new – it’s been used safely as an anesthetic in hospitals for decades. What is new is how doctors are using it at sub-anesthetic doses to treat mood and anxiety disorders with remarkable results. In a clinical infusion setting, ketamine works differently from every other psychiatric medication on the market today.
Rather than gradually shifting serotonin levels over weeks, ketamine targets the glutamate system – the brain’s primary excitatory signaling network. This allows it to rapidly promote the formation of new neural connections, essentially helping the brain “reset” patterns that have been reinforced by chronic stress or trauma.
For patients with PTSD, especially, this mechanism is significant. Traumatic memories and hypervigilance are partly sustained by entrenched neural pathways. Ketamine’s ability to promote neuroplasticity – the brain’s capacity to rewire itself – can loosen those patterns in ways other treatments simply can’t.
How Ketamine Affects the Brain
Understanding how ketamine affects mood and anxiety can help patients feel more prepared and confident going into treatment.
Here’s a simplified breakdown of what’s happening:
Glutamate modulation: Ketamine blocks NMDA receptors, which triggers a surge in glutamate activity. This cascade promotes the growth of new synaptic connections.
BDNF release: The treatment stimulates the release of brain-derived neurotrophic factor (BDNF), a protein that supports the survival and growth of neurons.
Default mode network changes: Ketamine temporarily disrupts the brain’s default mode network – the system involved in repetitive, self-referential thinking that often underlies anxious rumination.
Rapid symptom relief: Many patients notice a shift in anxiety or mood within 24–72 hours of their first infusion, long before traditional medications would begin to take effect.
These biological changes are why ketamine can feel different from anything patients have tried before. It isn’t masking symptoms – it’s actively changing the brain’s architecture.
Why Ketamine Is Considered a Breakthrough Treatment
The word “breakthrough” gets used a lot in medicine, but in this case, it’s earned. In 2019, the FDA approved esketamine (a nasal spray form of ketamine) for treatment-resistant depression – marking the first entirely new class of antidepressant approved in decades. While IV ketamine infusions are still administered off-label for anxiety and PTSD, this approval signaled a major shift in how the medical community views the compound’s therapeutic potential.
What sets ketamine apart as a breakthrough treatment isn’t just speed – it’s the population it helps. Patients who have exhausted multiple medications and years of therapy are finding relief through ketamine when nothing else worked. That’s not a minor development. That’s a paradigm shift.
The Increasing Evidence Behind Ketamine
Research on ketamine for anxiety and PTSD has grown substantially over the past decade. Clinical trials and peer-reviewed studies have repeatedly shown that IV ketamine produces significant reductions in PTSD symptom severity, often after just a handful of sessions. One randomized controlled trial published in JAMA Psychiatry found that patients with chronic PTSD experienced rapid and robust symptom improvement following a series of ketamine infusions, outperforming the placebo group by a meaningful margin.
The increasing evidence also points to ketamine’s durability when infusions are paired with psychotherapy. Many clinicians now offer ketamine-assisted therapy, where the neuroplastic window opened by the infusion is used as an opportunity for deeper therapeutic work. This combination approach is showing particular promise for patients with complex or long-standing trauma.
The Effects of Ketamine Therapy: What to Expect During Treatment
One of the biggest questions patients have is: What will I actually feel?
During an infusion, which typically lasts 40 to 60 minutes, patients are reclined in a comfortable chair or treatment bed. Vital signs are monitored throughout. The IV dose is carefully calibrated by your provider.
The experience varies from person to person, but common sensations include:
A mild floating or dreamlike feeling
Slight visual distortions or enhanced colors
A sense of detachment from the body or surroundings
Deep relaxation or, for some, vivid introspective thoughts
These effects fade quickly after the infusion ends. Most patients are alert and can converse normally within 30–45 minutes. Because of lingering drowsiness, driving is not permitted on infusion days – arrange a ride home.
A standard treatment course is typically 6 infusions over 2-3 weeks, though this varies by provider and patient response. Many patients begin noticing improvement after the second or third session.
What to Know About Ketamine Use in a Clinical Setting
Safety is a top priority in any medical setting, and responsible ketamine use in a supervised clinical environment is very well tolerated. Here are important points to keep in mind:
Side effects are generally mild and temporary. The most commonly reported ones include nausea, dizziness, and transient increases in blood pressure – all of which resolve quickly and can be managed by your care team.
Ketamine is not appropriate for everyone. People with certain cardiac conditions, a history of psychosis, or active substance use disorders may not be good candidates. A thorough intake evaluation, including a medical and psychiatric history, is standard before any treatment begins.
Finding Effective Relief: Is Ketamine Treatment Right for You?
Effective relief from anxiety or PTSD isn’t one-size-fits-all, and ketamine isn’t the first step for everyone. Most providers require that patients have tried at least 2 standard treatments without adequate results before recommending infusions.
The Effects of Ketamine on Long-Term Mental Health
Ketamine treatment is best understood as one component of a broader mental health strategy, not a standalone cure. For many patients, the relief it provides creates a window: a period of greater cognitive flexibility and reduced symptom burden during which therapy, lifestyle changes, and support systems can take hold more effectively.
If you’ve been living with treatment-resistant anxiety or PTSD, you deserve to know this option exists. Talk to a qualified provider, ask hard questions, and give yourself permission to explore what’s possible.
Spravato (Esketamine): A More Comfortable Alternative to Ketamine Infusions
For patients managing major depressive disorder, anxiety symptoms, or other mental health disorders who are looking for a more accessible treatment option, Spravato (esketamine) offers a compelling alternative to ketamine infusion therapy. Administered as a nasal spray in a certified clinical setting, Spravato delivers rapid and effective relief from treatment-resistant symptoms – without the need for an IV line. It’s a particularly well-suited option for those who may find infusions less practical or comfortable, yet still need meaningful support for more severe symptoms that haven’t responded to standard antidepressants.
At Sunshine Psychiatric Care & Wellness, Spravato treatment is provided in a calm, supervised environment with a care team focused on your comfort and long-term progress every step of the way.
Conclusion
Ketamine administration represents a genuine turning point for patients suffering from a wide range of mental health conditions, including social anxiety disorder, bipolar disorder, refractory anxiety, obsessive-compulsive disorder (OCD), and suicidal ideation. Unlike traditional antidepressants, ketamine’s rapid onset means it can quickly alleviate symptoms in ways that standard medications simply cannot, making it a vital treatment for anxiety and a powerful option to treat depression in patients unresponsive to conventional care. While its mild hallucinogenic effects and pain relief properties have long been recognized in medical settings, it’s the psychiatric potential that is now reshaping how clinicians approach mood disorders and treatment-resistant conditions.
For anyone who has cycled through treatment options without finding lasting relief, ketamine offers something rare – real hope, backed by science. Whether you’re exploring ketamine infusion therapy for the first time or seeking a more targeted approach to mood disorders, the team at Sunshine Psychiatric Care & Wellness is here to guide you. Every patient deserves access to care that works, and for those living with treatment-resistant or debilitating conditions, this may be the breakthrough that finally makes that possible.
About the Author
Rhonda Richardson, PMHNP-BC
Discover other insightful and engaging content from our blog
Your Mental Health
Together, we’ll create a treatment plan
that works for you.
